The proteasome - An emerging therapeutic target in cancer

被引:81
|
作者
Mitchell, BS [1 ]
机构
[1] Univ N Carolina, Div Hematol Oncol, Chapel Hill, NC 27514 USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2003年 / 348卷 / 26期
关键词
D O I
10.1056/NEJMp030092
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2597 / 2598
页数:2
相关论文
共 50 条
  • [21] Regulation of the Proteasome: Evaluating the Lung Proteasome as a New Therapeutic Target
    Meiners, Silke
    Keller, Ilona Elisabeth
    Semren, Nora
    Caniard, Anne
    ANTIOXIDANTS & REDOX SIGNALING, 2014, 21 (17) : 2364 - 2382
  • [22] Emerging Roles of SRSF3 as a Therapeutic Target for Cancer
    Zhou, Zhixia
    Gong, Qi
    Lin, Zhijuan
    Wang, Yin
    Li, Mengkun
    Wang, Lu
    Ding, Hongfei
    Li, Peifeng
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [23] ADAM17: An Emerging Therapeutic Target for Lung Cancer
    Saad, Mohamed, I
    Rose-John, Stefan
    Jenkins, Brendan J.
    CANCERS, 2019, 11 (09)
  • [24] TMPRSS4: an emerging potential therapeutic target in cancer
    A L de Aberasturi
    A Calvo
    British Journal of Cancer, 2015, 112 : 4 - 8
  • [25] Emerging Role of Apelin as a Therapeutic Target in Cancer: A Patent Review
    Rayalam, Srujana
    Della-Fera, Mary A.
    Kasser, Thomas
    Warren, William
    Baile, Clifton A.
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2011, 6 (03) : 367 - 372
  • [26] BTK inhibitors are a possible emerging therapeutic target for gastric cancer
    Portillo-Mino, Jose Dario
    Calderon, Jhon Jairo
    Riquelme, Arnoldo
    MOLECULAR THERAPY ONCOLOGY, 2025, 33 (01):
  • [27] FOXC1: an emerging marker and therapeutic target for cancer
    Han, B.
    Bhowmick, N.
    Qu, Y.
    Chung, S.
    Giuliano, A. E.
    Cui, X.
    ONCOGENE, 2017, 36 (28) : 3957 - 3963
  • [28] FOXC1: an emerging marker and therapeutic target for cancer
    B Han
    N Bhowmick
    Y Qu
    S Chung
    A E Giuliano
    X Cui
    Oncogene, 2017, 36 : 3957 - 3963
  • [29] Evaluation of the NRF1-proteasome axis as a therapeutic target in breast cancer
    Byers, Holly A.
    Brooks, Amy N.
    Vangala, Janakiram R.
    Grible, Jacqueline M.
    Feygin, Alex
    Clevenger, Charles V.
    Harrell, J. Chuck
    Radhakrishnan, Senthil K.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [30] Evaluation of the NRF1-proteasome axis as a therapeutic target in breast cancer
    Holly A. Byers
    Amy N. Brooks
    Janakiram R. Vangala
    Jacqueline M. Grible
    Alex Feygin
    Charles V. Clevenger
    J. Chuck Harrell
    Senthil K. Radhakrishnan
    Scientific Reports, 13